In addition, RBA nominated 6 other candidate ROS1 rearrangements, in breast cancer (BT-549, HS578t), glioblastoma (SF-295, U251), lung cancer (HOP-62), and angiosarcoma (AS1). Here, ROS1 is linked to angiosarcoma.